T1	Disorder 10 37	Diffuse alveolar hemorrhage
T2	Pharmacological_substance 44 55	leflunomide
N1000 	Reference T2 MeSH:C045463	leflunomide
T3	Disorder 82 102	rheumatoid arthritis
N1 	Reference T3 UMLS:C0003873	rheumatoid arthritis
T4	Disorder 152 172	rheumatoid arthritis
N2 	Reference T4 UMLS:C0003873	rheumatoid arthritis
T5	Disorder 218 228	hemoptysis
N3 	Reference T5 UMLS:C0019079	hemoptysis
T6	Pharmacological_substance 293 304	leflunomide
N1001 	Reference T6 MeSH:C045463	leflunomide
T7	Disorder 363 379	pleural effusion
N4 	Reference T7 UMLS:C0032227	pleural effusion
T8	Disorder 563 577	microhematuria
N5 	Reference T8 UMLS:C0239937	microhematuria
T9	Disorder 591 597	anemia
N6 	Reference T9 UMLS:C0002871	anemia
T10	Disorder 675 695	pulmonary hemorrhage
N7 	Reference T10 UMLS:C0151701	pulmonary hemorrhage
T11	Disorder 915 933	glomerulonephritis
N8 	Reference T11 UMLS:C0017658	glomerulonephritis
T12	Disorder 982 1009	diffuse alveolar hemorrhage
T13	Pharmacological_substance 1043 1054	leflunomide
N1002 	Reference T13 MeSH:C045463	leflunomide
T14	Disorder 1055 1079	pulmonary-renal syndrome
N9 	Reference T14 UMLS:C0403529	pulmonary-renal syndrome
N10 	Reference T14 UMLS:C0549143	pulmonary-renal syndrome
T15	Pharmacological_substance 1113 1124	leflunomide
N1003 	Reference T15 MeSH:C045463	leflunomide
T16	Subject 69 76	patient
T19	Disorder 190 216	apid-onset short-of-breath
T20	Disorder 234 249	severe weakness
N11 	Reference T20 UMLS:C3714552	severe weakness
T21	Subject 129 138	young man
T23	Disorder 454 474	diffuse ground-glass
N12 	Reference T23 UMLS:C0561146	diffuse ground-glass
T24	Disorder 479 509	interlobular septal thickening
T25	Disorder 331 358	central bilateral opacities
N13 	Reference T25 UMLS:C1265876	central bilateral opacities
